Golden
CHAIN Biotechnology

CHAIN Biotechnology

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

All edits

Edits 5 days ago
Carla Faraguna
Carla Faraguna edited 5 days ago
Edits made to:
Infobox (+1 properties)

Infobox

Location
Edits on 22 Jul 2019
Golden AI
Golden AI edited on 22 Jul 2019 11:03 pm
Edits made to:
Infobox (+1 properties)
Edits on 4 Apr 2019
Dawson Sewell
Dawson Sewell edited on 4 Apr 2019 5:09 pm
Edits made to:
Infobox (+7 properties)
Article (+318 characters)
Further reading (+1 rows) (+4 cells) (+227 characters)
Documentaries, videos and podcasts (+1 rows) (+3 cells) (+159 characters)
Related Topics (+3 topics)

Article

CHAIN Biotechnology is a biotechnology company using microbial technologies to develop healthcare products that is headquartered in Marlow, United Kingdom and was founded in 2014 by Basil Omar and Edward Green.



...



Funding

Grant

On September 12, 2017 CHAIN Biotechnology received a grant worth £500,000 from Innovative UK. 

Further reading

Title
Author
Link
Type

Biotech Focus: Interview with Dr Edward Green, CHAIN Biotechnology - Microbiome Times Magazine

Staff Editor

Web

Documentaries, videos and podcasts

Title
Date
Link

IChemE Awards 2016 Finalist - 'Clostridium for high-value chemical production', CHAIN Biotechnology

October 10, 2016

Infobox

Related Topics

Edits on 12 Feb 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 12 Feb 2019 10:41 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 11 Feb 2019
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 11 Feb 2019 11:40 am
Edits made to:
Infobox (+3 properties)
People (+1 rows) (+2 cells) (+19 characters)

People

Name
Role
Related Golden topics

Edward Green

Founder



Infobox

Edits on 11 Jan 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 11 Jan 2019 8:47 pm
Edits made to:
Article (+18/-18 characters)

Article

CHAIN’s treatment for Ulcerative ColitisUlcerative Colitis and Crohn’s Disease has been completed pre-clnical testing. Scaling up the manufacturing of the Clostridial spore-based medicines following good manufacturing practice (GMP) will be aided by Porton Biopharma and Scitech. Other products in development focus on treating infection, inflammation and metabolic disorders. 

Carla Faraguna
Carla Faraguna edited on 11 Jan 2019 6:26 pm
Edits made to:
Topic thumbnail

CHAIN Biotech CHAIN Biotechnology

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

Meredith Hanel
Meredith Hanel edited on 11 Jan 2019 6:23 pm
Edits made to:
Topic thumbnail

Chain Biotech CHAIN Biotech

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

Meredith Hanel
Meredith Hanel edited on 11 Jan 2019 6:20 pm
Edits made to:
Description (+340 characters)
Article (+833 characters)
People (+3 rows) (+6 cells) (+130 characters)
Categories (+2 topics)
Topic thumbnail

CHAIN Biotechnology

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

Article

CHAIN’s Clostridium Assisted Drug Delivery (CADD) platform is an engineered strain of Clostridium bacteria that functions as a delivery vehicle for therapeutics. Engineered strains are manufactured in the form of spores and taken as tablets. The spores tolerate stomach acid and acid they germinate the colon the cells proliferate and release a bioactive molecule. CHAIN has other products in development aimed at treating infection, inflammation and metabolic disorders. 



CHAIN’s treatment for Ulcerative Colitis and Crohn’s Disease has been completed pre-clnical testing. Scaling up the manufacturing of the Clostridial spore-based medicines following good manufacturing practice (GMP) will be aided by Porton Biopharma and Scitech. Other products in development focus on treating infection, inflammation and metabolic disorders. 

People

Name
Role
Related Golden topics

Dr. Edward M. Green

Founder, CEO



Mr. Basil Omar

Founder, Chief Commercial Officer



Mr. Robert James Rickman

Chairman of Management Board



Categories

Edits on 14 Nov 2018
Melanie Manipula"Approved suggestion from source: https://chainbiotech.com/"
Melanie Manipula approved a suggestion from Golden's AI on 14 Nov 2018 11:32 pm
Edits made to:
Infobox (+1 properties)
Edits on 14 Nov 2018
Jude Gomila"Approved suggestion from source: https://chainbiotech.com/"
Jude Gomila approved a suggestion from Golden's AI on 14 Nov 2018 3:10 am
Edits made to:
Infobox (+1 properties)
Edits on 25 Jul 2018
Melanie Manipula
Melanie Manipula edited on 25 Jul 2018 12:25 am
Edits on 20 Apr 2018
Melanie Manipula
Melanie Manipula edited on 20 Apr 2018 11:39 pm
Edits made to:
Topic thumbnail

CHAIN Biotechnology

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

Melanie Manipula"Initial topic creation"
Melanie Manipula created this topic on 20 Apr 2018 11:36 pm
Edits made to:
Description
Academic papers
People
Further reading
Documentaries, videos and podcasts
Companies
Products
Topic thumbnail

 Chain Biotech

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

No more activity to show.